Since 2013, Roche New Zealand has partnered with the Brain Health Research Centre, Otago University, to provide funding for the Hanns Mohler Doctoral Scholarship.
Professor Hanns Mohler, a very active researcher, has been instrumental in discovering targets for life changing medicines in the field of neuroscience and is one of the most cited scientists in his field.
The yearly grant of $10,000 is awarded by the Brain Health Research Centre and has enabled PhD students to complete their research. Breakthroughs that have positive impact on patients' lives do not come easily and this grant is designed to assist young scientists in New Zealand to pursue their own breakthroughs.
Hanns Möhler Scholars
2019 – Javier Jiminez Martin
Javier was awarded the grant in 2019 for his work which focused on developing a new imaging technology – through skull voltage imaging – which he is using to understand sensorimotor signals in the cerebral cortex of awake behaving mice.
2018 - Stephanie Mercer
Stephanie was awarded the grant in 2018 for her work which investigated the effects of rescuing lysosomal function in Alzheimer's disease.
2017 – Hannah Best
Hannah was awarded the grant in 2017 for her work which investigated disease processes into two different forms of Batten disease, a fatal, inherited disorder of the nervous system that begins in childhood. This work resulted in a publication reporting a new method for rapid screening of therapeutics for this disorder.
2016 - Madeleine Kyrke-Smith
Madeleine was awarded the grant in 2016 for her work which focused on the impact of DNA on memory formation. Her research could potentially path the way toward a better understanding of memory failures, and improved treatment for memory loss in illnesses such as Alzheimer’s disease.
2015 - Steve Seo
Steve was awarded the grant in 2015 for his research on the contribution of thalamic (grey matter) GABAA receptors in the generation of absence seizures, which have detrimental effects on childhood learning, psychosocial abilities and physical safety
2014 - Shane Hellyer
Shane was awarded the grant for his research into exploring the possibility of toxins in Algae bloom being the source of possible future therapies for neurological conditions such as Alzheimer’s, Parkinson’s, autism and schizophrenia.